| TTM
|
6/30/2026
|
6/30/2025
|
6/30/2024
|
6/30/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
13,799,000 | 12,195,000 | 9,097,000 | 6,551,000 | 7,384,000 |
|
Cost of Revenue
|
-6,851,000 | -6,637,000 | -5,897,000 | -5,015,000 | -6,033,000 |
|
Gross Profit
|
6,948,000 | 5,558,000 | 3,200,000 | 1,536,000 | 1,351,000 |
|
Selling, General and Administrative Expenses
|
-592,000 | -577,000 | -561,000 | -460,000 | -491,000 |
|
Research and Development Expenses
|
-769,000 | -755,000 | -724,000 | -654,000 | -797,000 |
| Depreciation, Amortization and Depletion
|
0 | -- | 0 | 0 | -3,000 |
|
Operating Income/Expenses
|
-1,361,000 | -1,332,000 | -1,285,000 | -1,114,000 | -1,291,000 |
|
Total Operating Profit/Loss
|
5,587,000 | 4,226,000 | 1,915,000 | 422,000 | 60,000 |
| Total Net Finance Income/Expense
|
-215,000 | -254,000 | -296,000 | -317,000 | -303,000 |
| Net Investment Income
|
0 | 0 | 0 | 104,000 | 0 |
| Irregular Income/Expenses
|
-312,000 | -283,000 | -24,000 | 314,000 | -212,000 |
|
Other Income/Expense, Non-Operating
|
-2,000 | 1,000 | -82,000 | -78,000 | -41,000 |
|
Non-Operating Income/Expenses, Total
|
-529,000 | -536,000 | -402,000 | 23,000 | -556,000 |
|
Pretax Income
|
5,058,000 | 3,690,000 | 1,513,000 | 445,000 | -496,000 |
|
Provision for Income Tax
|
-662,000 | -506,000 | -44,000 | -110,000 | -33,000 |
|
Net Income from Continuing Operations
|
4,396,000 | 3,184,000 | 1,469,000 | 335,000 | -529,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
4,396,000 | 3,184,000 | 1,469,000 | 335,000 | -529,000 |
|
Net Income after Non-Controlling/Minority Interests
|
4,396,000 | 3,184,000 | 1,469,000 | 335,000 | -529,000 |
|
Net Income Available to Common Stockholders
|
4,396,000 | 3,184,000 | 1,469,000 | 335,000 | -529,000 |
|
Diluted Net Income Available to Common Stockholders
|
4,396,000 | 3,184,000 | 1,469,000 | 335,000 | -529,000 |
|
Common Dividend per Share
|
2.96 | 2.94 | 2.86 | 2.80 | 2.80 |
| Basic EPS
|
19.60 | 14.54 | 6.93 | 1.60 | -2.56 |
| Diluted EPS
|
19.04 | 13.90 | 6.77 | 1.58 | -2.56 |
|
Basic Weighted Average Shares Outstanding
|
222,740.15 | 218,990.15 | 211,990.46 | 208,990.60 | 206,990.69 |
|
Diluted Weighted Average Shares Outstanding
|
230,489.70 | 228,989.70 | 216,990.24 | 211,990.46 | 206,990.69 |
|
Reported Normalized Diluted EPS
|
20.60 | 15.58 | 8.10 | 1.29 | 0.19 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
5,273,000 | 3,944,000 | 1,809,000 | 762,000 | -193,000 |
|
EBITDA
|
5,553,000 | 4,220,000 | 2,060,000 | 1,026,000 | 320,000 |
|
Normalized EBITDA
|
6,094,000 | 4,708,000 | 2,349,000 | 839,000 | 647,000 |
6/30/2023 - 12/11/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade